Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 18 de 18
Filtrar
4.
J Investig Allergol Clin Immunol ; 31(3): 236-245, 2021 Jun 22.
Artigo em Inglês | MEDLINE | ID: mdl-31932275

RESUMO

BACKGROUND: Atopic dermatitis is a chronic inflammatory skin disease with a prevalence of 0.02% to 8.1% in adults. Adult patients with moderate-to-severe atopic dermatitis are affected by frequent relapses and a significant disease burden. Objective: To determine the clinical, immunological, and therapeutic profile of Brazilian adults with atopic dermatitis. METHODS: A multicenter, observational, retrospective, descriptive registry-based study was conducted at reference hospitals between December 2016 and October 2017. The data collected were demographics, personal and family history of atopic diseases, clinical manifestations, laboratory tests, disease severity and management. RESULTS: Of the 187 patients included in the analysis, 56.1% were female and 71.7% were White, with a mean age of 24.7 years. Mean follow-up was 9 years. Asthma or other allergic diseases were reported by 80.2% of patients. The main comorbidity was hypertension (10.2%), and common disease manifestations included pruritus and erythema. Lesions generally affected flexural and nonflexural areas, with typical morphology. Around 83% of patients had moderate-to-severe disease, and 8.6% reported at least 1 hospitalization. Most patients received topical and/or systemic pharmacological therapies, including omalizumab (5.9%); 4.3% received phototherapy. Moreover, 66.8% of patients received adjuvant therapy, and 79.1% changed or discontinued treatment for atopic dermatitis due to remission (46.5%), poor effectiveness (33.7%), or lack of adherence (12.9%). Most patients presented characteristics of type 2 inflammation, with immunoglobulin E levels above 100 IU/mL (94.4%) and peripheral blood eosinophils above 5% (55.9%). CONCLUSION: Brazilian adult patients with severe atopic dermatitis need treatment to efficiently control the disease and improve quality of life.


Assuntos
Dermatite Atópica/imunologia , Eosinófilos/imunologia , Hipertensão/epidemiologia , Omalizumab/uso terapêutico , Adulto , Brasil/epidemiologia , Comorbidade , Demografia , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/epidemiologia , Progressão da Doença , Eritema , Feminino , Seguimentos , Hospitalização/estatística & dados numéricos , Humanos , Imunoglobulina E/sangue , Masculino , Prurido , Centros de Atenção Terciária
5.
J. investig. allergol. clin. immunol ; 31(3): 236-245, 2021. tab, graf
Artigo em Inglês | IBECS | ID: ibc-215205

RESUMO

Background: Atopic dermatitis is a chronic inflammatory skin disease with a prevalence of 0.02% to 8.1% in adults. Adult patients with moderate-to-severe atopic dermatitis are affected by frequent relapses and a significant disease burden. Objective: To determine the clinical, immunological, and therapeutic profile of Brazilian adults with atopic dermatitis. Methods: A multicenter, observational, retrospective, descriptive registry-based study was conducted at reference hospitals between December 2016 and October 2017. The data collected were demographics, personal and family history of atopic diseases, clinical manifestations, laboratory tests, disease severity and management. Results: Of the 187 patients included in the analysis, 56.1% were female and 71.7% were White, with a mean age of 24.7 years. Mean follow-up was 9 years. Asthma or other allergic diseases were reported by 80.2% of patients. The main comorbidity was hypertension (10.2%), and common disease manifestations included pruritus and erythema. Lesions generally affected flexural and nonflexural areas, with typical morphology. Around 83% of patients had moderate-to-severe disease, and 8.6% reported at least 1 hospitalization. Most patients received topical and/or systemic pharmacological therapies, including omalizumab (5.9%); 4.3% received phototherapy. Moreover, 66.8% of patients received adjuvant therapy, and 79.1% changed or discontinued treatment for atopic dermatitis due to remission (46.5%), poor effectiveness (33.7%), or lack of adherence (12.9%). Most patients presented characteristics of type 2 inflammation, with immunoglobulin E levels above 100 IU/mL (94.4%) and peripheral blood eosinophils above 5% (55.9%). Conclusion: Brazilian adult patients with severe atopic dermatitis need treatment to efficiently control the disease and improve quality of life (AU)


Assuntos
Humanos , Masculino , Feminino , Adulto Jovem , Adulto , Dermatite Atópica/imunologia , Eosinófilos/imunologia , Omalizumab/uso terapêutico , Antialérgicos/uso terapêutico , Estudos Retrospectivos , Brasil/epidemiologia , Comorbidade , Dermatite Atópica/tratamento farmacológico , Dermatite Atópica/epidemiologia , Progressão da Doença , Seguimentos , Hospitalização/estatística & dados numéricos , Imunoglobulina E/sangue , Atenção Terciária à Saúde
11.
J. Am. Acad. Dermatol ; 67(3): p.331.e1-.e14, 2012.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP | ID: but-ib9289
12.
Rev. argent. dermatol ; 92(4): 2-10, dic. 2011. ilus, tab
Artigo em Espanhol | LILACS | ID: lil-634441

RESUMO

La lepra en la infancia cursa con una diversidad de manifestaciones clínicas e histopatológicas, que hacen necesario un minucioso examen cutáneo en todo niño, que presente lesiones dermatológicas sugestivas y una fuente infecciosa sospechosa. Para un oportuno diagnóstico es indispensable que el médico tenga siempre presente la enfermedad, así como destreza al realizar el examen clínico, ya que muchas lesiones cutáneas suelen ser asintomáticas y con frecuencia simulan otros cuadros dermatológicos. Presentamos tres casos de pacientes erróneamente diagnosticados, tratados por otras dermatosis y quienes finalmente estaban afectados de lepra.


Leprosy in childhood course with a diversity of clinical and histopathological signs that make necessary a detailed cutaneous inspection in every child that presents suggestive dermatological lesions, have had a suspected infectious contact. For an appropriate diagnosis, is very important to keep in mind the disease, as well as medical clinical skill because many skin and nerve lesions can be asymptomatic and frequently look like other dermatological pathology. The authors report three cases of children misdiagnosed and treated for other dermatosis and whom finally were found leprosy´s patients.

13.
J Am Acad Dermatol ; 61(5): p.733-50, 2009.
Artigo em Inglês | Sec. Est. Saúde SP, SESSP-IBPROD, Sec. Est. Saúde SP | ID: but-ib9287
14.
J Eur Acad Dermatol Venereol ; 20(9): 1037-45, 2006 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-16987255

RESUMO

Prion diseases are transmissible spongiform encephalopathies of humans and animals. The oral route is clearly associated with some prion diseases, according to the dissemination of bovine spongiform encephalopathy (BSE or mad cow disease) in cattle and kuru in humans. However, other prion diseases such as scrapie (in sheep) and chronic wasting disease (CWD) (in cervids) cannot be explained in this way and are probably more associated with a pattern of horizontal transmission in both domestic and wild animals. The skin and mucous membranes are a potential target for prion infections because keratinocytes and lymphocytes are susceptible to the abnormal infective isoform of the prion protein. Iatrogenic transmission of Creutzfeldt-Jakob disease (CJD) was also recognized after corneal transplants in humans and scrapie was successfully transmitted to mice after ocular instillation of infected brain tissue, confirming that these new routes could also be important in prion infections. Some ectoparasites have been proven to harbour prion rods in laboratory experiments. Prion rods were identified in both fly larvae and pupae; adult flies are also able to express prion proteins. The most common causes of myiasis in cattle and sheep, closely related animals with previous prion infections, are Hypoderma bovis and Oestrus ovis, respectively. Both species of flies present a life cycle very different from human myiasis, as they have a long contact with neurological structures, such as spinal canal and epidural fat, which are potentially rich in prion rods. Ophthalmomyiases in humans is commonly caused by both species of fly larvae worldwide, providing almost direct contact with the central nervous system (CNS). The high expression of the prion protein on the skin and mucosa and the severity of the inflammatory response to the larvae could readily increase the efficiency of transmission of prions in both animals and humans.


Assuntos
Miíase/complicações , Doenças Priônicas/etiologia , Animais , Humanos , Fatores de Risco
15.
Surg Endosc ; 20(9): 1440-7, 2006 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-16703442

RESUMO

BACKGROUND: The immunologic repercussions due to cavity insufflation are the focus of great discussion. The aim of this study was to compare the inflammatory response and bacterial dissemination after laparotomy and abdominal CO2 insufflation in a murine model of peritonitis. METHODS: Swiss mice were inoculated intraperitoneally with 0.5 ml of a solution containing 1 x 10(8) colony-forming units (CFU)/ml of Escherichia coli and were divided into three groups as follow: control (anesthesia for 30 min), laparotomy (2.5-cm midline incision for 30 min), and CO2 pneumoperitoneum (CO2 cavity insufflation for 30 min). The number of leukocytes, CFU/ml counting, and the levels of interleukin (IL)-6, tumor necrosis factor-alpha (TNF-alpha), and IL-10 were evaluated in blood, peritoneal, and pleural fluid samples obtained at 90 min and 18 h after the procedures. RESULTS: The laparotomy group showed a greater bacterial dissemination to the blood, peritoneum, and pleural cavity and also greater neutrophil migration to the peritoneal cavity compared to the CO2 insufflated and control groups. The 24-h mortality was also significantly higher in the laparotomy group. The IL-6 levels showed a precocious rise in all groups submitted to bacterial inoculation at the 90-min time point. At the 18-h time point, IL-6 levels in the peritoneum were significantly higher in the laparotomy group than in the control or CO2 insufflated groups. At the same time, TNF-alpha levels were higher in the laparotomy and CO2 insufflated groups than in controls; IL-10 levels showed no differences among the groups. CONCLUSIONS: Our results suggest that cavity insufflation with CO2 is a more effective method of access, inducing less bacterial dissemination and also a less intense inflammatory response. Cavity insufflation with CO2 may present a good option for the surgical treatment of patients with bacterial peritonitis.


Assuntos
Translocação Bacteriana , Dióxido de Carbono , Inflamação/etiologia , Insuflação/efeitos adversos , Laparotomia/efeitos adversos , Peritonite/cirurgia , Animais , Sangue/microbiologia , Contagem de Células Sanguíneas , Citocinas/sangue , Escherichia coli/fisiologia , Insuflação/normas , Laparotomia/mortalidade , Masculino , Camundongos
16.
s.l; s.n; 2006. 19 p. ilus.
Não convencional em Inglês | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1241873

RESUMO

Bacterial infections are common in tropical parts of the world and can include those species also seen regularly in temperate climates. Many tropical bacterial infections, however, are rarely diagnosed in temperate parts of the world and include bartonellosis, tropical ulcer, tropical pyomyositis, granuloma inguinale, lymphogranuloma venereum, yaws, pinta, melioidosis, and glanders. Some tropical bacterial diseases, eg, plague and anthrax, are associated with high mortality rates and are of potential use in bioterrorism. Some tropical bacterial diseases are closely associated with specific activities such as hunting (ie, tularemia) or eating raw seafood (Vibrio vulnificus infection). The bacterial diseases having the most severe medical impact in the tropics are those caused by members of the Mycobacterium genus. Millions of persons throughout the world suffer from tuberculosis and leprosy; Buruli ulcers are common causes of morbidity in many tropical countries. Because of the increasing frequency of travel to tropical parts of the world for tourism and work as well as the increasing number of immigrants and adoptees from these areas, it is imperative that physicians practicing in temperate climates be able to recognize the signs and symptoms of tropical bacterial diseases, carry out the proper diagnostic tests, and initiate appropriate therapy and prevention. LEARNING OBJECTIVE: At the completion of this learning activity, participants should be familiar with the clinical presentations, epidemiologies, diagnoses, therapies, and preventions of bacterial tropical diseases...


Assuntos
Humanos , Dermatopatias Bacterianas/complicações , Dermatopatias Bacterianas/fisiopatologia , Dermatopatias Bacterianas/prevenção & controle , Dermatopatias Bacterianas/reabilitação , Dermatopatias Bacterianas/terapia , Doenças Transmissíveis/complicações , Doenças Transmissíveis/epidemiologia , Doenças Transmissíveis/fisiopatologia , Infecções Bacterianas/complicações , Infecções Bacterianas/diagnóstico , Infecções Bacterianas/fisiopatologia , Infecções Bacterianas/reabilitação , Infecções Bacterianas/terapia
17.
J Eur Acad Dermatol Venereol ; 18(5): 622-5, 2004 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-15324412

RESUMO

Pityriasis rosea (PR) is a relatively common disease although its aetiology has not yet been identified. It occurs worldwide and there is no racial susceptibility factor. It usually affects teenagers and young adults between 10 and 35 years of age. Typical PR is much easier to diagnose than the rare atypical forms. We report a rare case of vesicular PR in a black woman who had vesicular lesions limited to her palms and soles in addition to regular typical lesions. We devised an efficient oral erythromycin treatment for this patient.


Assuntos
Pitiríase Rósea/diagnóstico , Administração Oral , Adulto , Antibacterianos/administração & dosagem , Diagnóstico Diferencial , Eritromicina/administração & dosagem , Feminino , , Mãos , Humanos , Pitiríase Rósea/patologia
18.
Biochemistry ; 35(13): 3886-91, 1996 Apr 02.
Artigo em Inglês | MEDLINE | ID: mdl-8672418

RESUMO

Erythrosin B and eosin Y stimulate p-nitrophenyl phosphate hydrolysis by purified sarcoplasmic reticulum Ca(2+)-ATPase by nearly 2-3 fold in the presence of Ca(2+). This stimulation is not due to the change on the apparent affinity for substrate but is indeed due to acceleration of the turnover rate of the enzyme. Stimulation reaches a maximum at approximately 5 microM erythrosin or 20 microM eosin and is strictly dependent on the presence of Ca(2+) in reaction media, while higher concentrations of dye progressively inhibit phosphatase activity. Labeling with fluorescein isothiocyanate (FITC) largely shifts the Km for p-nitrophenyl phosphate (pNPP) and completely abolishes the stimulation of phosphatase activity induced by erythrosin in the presence of Ca(2+), apparently by FITC impairing dye binding to an activator site and allowing only manifestation of an inhibitory binding site. In the absence of Ca(2+), both erythrosin and eosin inhibit pNPP hyrolysis with Ic50 values 3-4 fold higher than the maximally stimulatory enzyme with FITC, which by its turn does not affect pNPPase activity in absence of Ca(2+). It is suggested that stimulation and inhibition of phosphatase activity are related to two simultaneous and physically different nucleotide analog binding sites.


Assuntos
4-Nitrofenilfosfatase/metabolismo , ATPases Transportadoras de Cálcio/química , ATPases Transportadoras de Cálcio/metabolismo , Músculo Esquelético/enzimologia , Ribonucleotídeos/metabolismo , Retículo Sarcoplasmático/enzimologia , 4-Nitrofenilfosfatase/química , Animais , Sítios de Ligação , Cálcio/metabolismo , Amarelo de Eosina-(YS)/farmacologia , Eritrosina/farmacologia , Hidrólise , Cinética , Nitrofenóis/metabolismo , Compostos Organofosforados/metabolismo , Coelhos , Especificidade por Substrato
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...